146 related articles for article (PubMed ID: 36692828)
1. Anti-ovarian cancer actions and pharmacological targets of plumbagin.
Liang K; Pan X; Chen Y; Huang S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jun; 396(6):1205-1210. PubMed ID: 36692828
[TBL] [Abstract][Full Text] [Related]
2. Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG-1 ovarian cancer cells.
Srinivas G; Annab LA; Gopinath G; Banerji A; Srinivas P
Mol Carcinog; 2004 Jan; 39(1):15-25. PubMed ID: 14694444
[TBL] [Abstract][Full Text] [Related]
3. Plumbagin from a tropical pitcher plant (Nepenthes alata Blanco) induces apoptotic cell death via a p53-dependent pathway in MCF-7 human breast cancer cells.
De U; Son JY; Jeon Y; Ha SY; Park YJ; Yoon S; Ha KT; Choi WS; Lee BM; Kim IS; Kwak JH; Kim HS
Food Chem Toxicol; 2019 Jan; 123():492-500. PubMed ID: 30458268
[TBL] [Abstract][Full Text] [Related]
4. Structure activity relationship of plumbagin in BRCA1 related cancer cells.
K A T; T R; G R; K C S; Nair RS; G S; Banerji A; Somasundaram V; Srinivas P
Mol Carcinog; 2013 May; 52(5):392-403. PubMed ID: 22290577
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents.
Thasni KA; Rakesh S; Rojini G; Ratheeshkumar T; Srinivas G; Priya S
Ann Oncol; 2008 Apr; 19(4):696-705. PubMed ID: 18187487
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma.
Zhou R; Wu K; Su M; Li R
Environ Toxicol Pharmacol; 2019 Aug; 70():103200. PubMed ID: 31158732
[TBL] [Abstract][Full Text] [Related]
7. Proapoptotic and Growth-inhibitory Effects of Plumbagin on Human Gastric Cancer Cells Via Suppression of Signal Transducer and Activator of Transcription 3 and Protein Kinase B.
Li J; Li J; Cai G; Shen L; Lu F
Altern Ther Health Med; 2017 Sep; 23(5):42-48. PubMed ID: 28236621
[TBL] [Abstract][Full Text] [Related]
8. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL
Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967
[TBL] [Abstract][Full Text] [Related]
9. Plumbagin induces growth inhibition of human glioma cells by downregulating the expression and activity of FOXM1.
Liu X; Cai W; Niu M; Chong Y; Liu H; Hu W; Wang D; Gao S; Shi Q; Hu J; Zhou X; Yu R
J Neurooncol; 2015 Feb; 121(3):469-77. PubMed ID: 25528634
[TBL] [Abstract][Full Text] [Related]
10. Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells.
Kuo PL; Hsu YL; Cho CY
Mol Cancer Ther; 2006 Dec; 5(12):3209-21. PubMed ID: 17172425
[TBL] [Abstract][Full Text] [Related]
11. Plumbagin: A Potential Anti-cancer Compound.
Roy A
Mini Rev Med Chem; 2021; 21(6):731-737. PubMed ID: 33200707
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress induced by the anti-cancer agents, plumbagin, and atovaquone, inhibits ion transport through Na
Alharbi Y; Kapur A; Felder M; Barroilhet L; Pattnaik BR; Patankar MS
Sci Rep; 2020 Nov; 10(1):19585. PubMed ID: 33177587
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis inducing effect of plumbagin on colonic cancer cells depends on expression of COX-2.
Subramaniya BR; Srinivasan G; Sadullah SS; Davis N; Subhadara LB; Halagowder D; Sivasitambaram ND
PLoS One; 2011 Apr; 6(4):e18695. PubMed ID: 21559086
[TBL] [Abstract][Full Text] [Related]
14. In silico analysis and experimental validation to exhibit anti-nasopharyngeal carcinoma effects of plumbagin, an anti-cancer compound.
Liang X; Pan Q; Liao Y; Nie L; Yang L; Liu F; Su M
J Sci Food Agric; 2022 Sep; 102(12):5460-5467. PubMed ID: 35355274
[TBL] [Abstract][Full Text] [Related]
15. Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice.
Yan W; Wang TY; Fan QM; Du L; Xu JK; Zhai ZJ; Li HW; Tang TT
Acta Pharmacol Sin; 2014 Jan; 35(1):124-34. PubMed ID: 24384612
[TBL] [Abstract][Full Text] [Related]
16. The role of thioredoxin reductase and glutathione reductase in plumbagin-induced, reactive oxygen species-mediated apoptosis in cancer cell lines.
Hwang GH; Ryu JM; Jeon YJ; Choi J; Han HJ; Lee YM; Lee S; Bae JS; Jung JW; Chang W; Kim LK; Jee JG; Lee MY
Eur J Pharmacol; 2015 Oct; 765():384-93. PubMed ID: 26341012
[TBL] [Abstract][Full Text] [Related]
17. The anti-tumor effect of OP-B on ovarian cancer in vitro and in vivo, and its mechanism: An investigation using network pharmacology-based analysis.
Yuan S; Xu Y; Yi T; Wang H
J Ethnopharmacol; 2022 Jan; 283():114706. PubMed ID: 34614446
[TBL] [Abstract][Full Text] [Related]
18. Plumbagin alters telomere dynamics, induces DNA damage and cell death in human brain tumour cells.
Khaw AK; Sameni S; Venkatesan S; Kalthur G; Hande MP
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():86-95. PubMed ID: 26520377
[TBL] [Abstract][Full Text] [Related]
19. Cleistopholine isolated from Enicosanthellum pulchrum exhibits apoptogenic properties in human ovarian cancer cells.
Nordin N; Majid NA; Mohan S; Dehghan F; Karimian H; Rahman MA; Ali HM; Hashim NM
Phytomedicine; 2016 Apr; 23(4):406-16. PubMed ID: 27002411
[TBL] [Abstract][Full Text] [Related]
20. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]